Abstract
Recent evidence highlights the therapeutic potential of Astragali radix-Huaier fermentation products for hyperuricemia treatment, although the dynamics of the fermentation process remain poorly understood. This study employed high-resolution mass spectrometry and untargeted metabolomics for real-time monitoring of chemical components and hypouricemic activity throughout fermentation. The results revealed significant alterations in the chemical composition, with distinct sample separations observed on days 7, 14, 21, and 28. A total of 33 differential components were identified, including 20 flavonoids and 13 saponins, eight of which showed notable changes. Polysaccharides and saponins were found to correlate positively with the uric acid-lowering effect. On day 21, the levels of total polysaccharides and cycloastragenol-6-glucoside, a saponin derivative, peaked, coinciding with the highest hypouricemic activity of the Astragalus fungal fermentation products. This study provides the first evidence of dynamic changes in the chemical profile and pharmacological activity of Astragali radix-Huaier during fermentation, paving the way for optimizing fermentation processes and developing medicinal and dietary products based on Astragali radix.
Funding Information
  • National Natural Science Foundation of China (82174039)
  • Taishan Young Scholar Program of Shandong (TSQN202103110)
  • Matching Support Program for Provincial and Above Leading Talents in Yantai City (10073801)
  • Special Project for Traditional Chinese Medicine Technological Innovation Project of Binzhou Medical University (2024ZYYZX09)
  • Fundamental Research Funds for the Central Universities (202410440012)
  • Fundamental Research Funds for the Central Universities (X202410440060)
  • The Science and Technology Project of the State Administration for Market Regulation of China (2024MK078)

This publication has 50 references indexed in Scilit: